Association Between Levonorgestrel-Releasing Intrauterine System Exposure Duration and Breast Cancer Incidence

The LNG-IUS may be associated with an increased risk of breast cancer among women with abnormal uterine bleeding, endometriosis, or leiomyomas, with the risk being particularly elevated during the initial years of use.